Iron chelators and exogenic photosensitizers. Synergy through oxidative stress gene expression

16Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

In non-invasive anticancer photodynamic therapy (PDT), a nontoxic photosensitizer (PS), which is activated by visible light, is used as a magic bullet that selectively destroys cancer cells. Recently, we described the combined therapy of 5-aminolevulinic acid (ALA-PDT) with thiosemicarbazone (TSC), i.e. an iron-chelating agent. This resulted in a strong synergistic effect. Herein, we investigated a novel strategy using a combination of PDT consist of the xenobiotic-porphyrin type PS with TSC. We observed a synergistic effect for all of the pairs of TSC-PS. This approach can be rationalized by the fact that both chlorin and TSC can affect the generation of reactive oxygen species (ROS). In order to elucidate the plausible mechanism of action, we also combined the investigated PSs with DFO, which forms complexes that are redox inactive. We detected a slight antagonism or additivity for this combination. This may suggest that the ability of an iron chelator (IC) to participate in the production of ROS and the generation of oxidative stress is important.

Cite

CITATION STYLE

APA

Mrozek-Wilczkiewicz, A., Malarz, K., Rams-Baron, M., Serda, M., Bauer, D., Montforts, F. P., … Musiol, R. (2017). Iron chelators and exogenic photosensitizers. Synergy through oxidative stress gene expression. Journal of Cancer, 8(11). https://doi.org/10.7150/jca.17959

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free